Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Ebrahimi
Switch From a ZDV/3TC-based Regimen to a Completely Once Daily (QD) Regimen of Emtricitabine/Tenofovir DF Fixed Dose Combination Plus a Third QD Agent (SONETT)
European Journal of Medical Research
Medicine
Related publications
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
School–Supervised Use of a Once-Daily Inhaled Corticosteroid Regimen: A Cluster Randomized Trial
Pediatrics
Child Health
Pediatrics
Perinatology
Effect of a Fixed-Dose Combination of Emtricitabine, Tenofovir and Efavirenz on Adherence and Treatment Acceptability (ADONE Study)
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Metabolic Evaluation of Study M05-730: LPV/r Tablets QD vs. BID, Co-Administered With Tenofovir DF + Emtricitabine in ARV-naïve HIV-1 Infected Subjects
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Chromatographic Separation and in Vitro Dissolution Assessment of Tenofovir Disoproxil Fumarate, Emtricitabine and Nevirapine in a Fixed Dose Combination of Antiretrovirals
Journal of Applied Pharmaceutical Science
Medicine
Toxicology
Pharmaceutics
Pharmacology
Points: A Regimen of Low Dose Aspirin
BMJ
Switch From Tenofovir Disoproxil Fumarate Combination to Dolutegravir Plus Rilpivirine Improves Parameters of Bone Health
AIDS
Infectious Diseases
Allergy
Immunology
Spacing Between Doses on a Thrice-Daily Regimen.
BMJ
